🇺🇸 FDA
Pipeline program

DUOFAG, Chlorid sodný B. Braun 0,9 % infuzní roztok

DUO2025_01

Phase 3 small_molecule active

Quick answer

DUOFAG, Chlorid sodný B. Braun 0,9 % infuzní roztok for Complicated skin wounds (wounds healing per secundam via granulation tissue) - either as a complication of healing of acute wounds (infected surgical or traumatic wounds) or chronic wounds, in both cases infected with S. aureus and/or P. aeruginosa. is a Phase 3 program (small_molecule) at Pharma Mar S.A. with 1 ClinicalTrials.gov record(s).

Program details

Company
Pharma Mar S.A.
Indication
Complicated skin wounds (wounds healing per secundam via granulation tissue) - either as a complication of healing of acute wounds (infected surgical or traumatic wounds) or chronic wounds, in both cases infected with S. aureus and/or P. aeruginosa.
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials